CONVERGENE LLC has a total of 26 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are MAXIA PHARMACEUTICALS INC, GUANGZHOU BAIYUNSHAN PHARMACEU and ARCHIFAR LAB CHIM FARM.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | China | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | WIPO (World Intellectual Property Organization) | 3 | |
#7 | Republic of Korea | 2 | |
#8 | Brazil | 1 | |
#9 | Hong Kong | 1 | |
#10 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Yoshioka Makoto | 23 |
#2 | Padia Janak Khimchand | 16 |
#3 | Strovel Jeffrey William | 16 |
#4 | Vankayalapati Hariprasad | 9 |
#5 | Maloney David J | 6 |
#6 | Yang Shyh Ming | 6 |
#7 | Jadhav Ajit | 6 |
#8 | Urban Daniel Jason | 5 |
#9 | Strovel Jefferey William | 5 |
#10 | Hariprasad Vankayalapati | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020219168A1 | Small molecule bromodomain inhibitors and uses thereof | |
EP3380469A1 | Bicyclic bet bromodomain inhibitors and uses thereof | |
CA2966908A1 | Methods and compositions for inhibition of bromodomain and extraterminal proteins | |
KR20150135359A | Methods and compositions for inhibition of bromodomain-containing proteins |